| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJCARD.2004.12.041 |
| P8608 | Fatcat ID | release_quy2rlxgdff3bovvwro2fsskwe |
| P698 | PubMed publication ID | 15982504 |
| P50 | author | Panagiotis Korantzopoulos | Q88365196 |
| P2093 | author name string | Theofilos M Kolettis | |
| John A Goudevenos | |||
| Eugenia Pappa | |||
| Evaggelos Kountouris | |||
| Konstantinos Siogas | |||
| Vasiliki Dimitroula | |||
| Pavlos Karanikis | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin C | Q199678 |
| atrial fibrillation | Q815819 | ||
| cardioversion | Q1729126 | ||
| P304 | page(s) | 321-326 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | International Journal of Cardiology | Q2357863 |
| P1476 | title | Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation | |
| P478 | volume | 102 |
| Q42338565 | A day without orange juice is like an invitation to atrial fibrillation |
| Q39653047 | A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation. |
| Q37421235 | A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein |
| Q37697124 | A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). |
| Q28301541 | A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk |
| Q37656338 | Adjuvant therapy for atrial fibrillation |
| Q35062038 | Alternative medicine in atrial fibrillation treatment-Yoga, acupuncture, biofeedback and more |
| Q37339307 | Antioxidant therapies for the management of atrial fibrillation |
| Q35184349 | Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence? |
| Q38202561 | Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis |
| Q85001945 | Ascorbic acid mitigates the myocardial injury after cardiac arrest and electrical shock |
| Q84145691 | Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation |
| Q36993220 | Atrial Fibrillation on Intensive Care Unit Admission Independently Increases the Risk of Weaning Failure in Nonheart Failure Mechanically Ventilated Patients in a Medical Intensive Care Unit: A Retrospective Case-Control Study |
| Q39300430 | Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications |
| Q37821236 | Atrial fibrillation and inflammation |
| Q27693290 | Atrial fibrillation: inflammation in disguise? |
| Q37115344 | C-Reactive Protein and The Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis |
| Q38728458 | Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction |
| Q92425485 | Comparison Effect of Tranexamic Acid (TA) and Tranexamic Acid Combined with Vitamin C (TXC) on Drainage Volume and Atrial Fibrillation Arrhythmia in Patients Undergoing Cardiac Bypass Surgery: Randomized Clinical Trial |
| Q97073587 | Comparison of apolipoprotein-A1 levels between paroxysmal atrial fibrillation patients and healthy subjects |
| Q26770909 | Compromised redox homeostasis, altered nitroso-redox balance, and therapeutic possibilities in atrial fibrillation |
| Q38234313 | Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies |
| Q39078008 | Does aortic valve disease etiology predict postoperative atrial fibrillation in patients undergoing aortic valve surgery? |
| Q84800305 | Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery |
| Q55254736 | Effect of vitamin C on azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated early colon cancer in mice. |
| Q92604420 | Effects of N-acetyl cysteine, vitamin E and vitamin C on liver glutathione levels following amiodarone treatment in rats |
| Q33760508 | Functional Foods as Modifiers of Cardiovascular Disease |
| Q35164974 | Heat shock proteins in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery |
| Q38233801 | Inflammation and arrhythmias: potential mechanisms and clinical implications. |
| Q35557385 | Inflammatory cytokines and atrial fibrillation: current and prospective views |
| Q34704572 | Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? |
| Q36309624 | Is atrial fibrillation an inflammatory disorder? |
| Q35187745 | Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. |
| Q39323610 | May toxicity of amiodarone be prevented by antioxidants? A cell-culture study. |
| Q34171904 | N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials |
| Q36841963 | Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation |
| Q36015478 | Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. |
| Q38025390 | Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation. |
| Q42368137 | Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes |
| Q34651371 | Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase |
| Q39024113 | Perspectives and challenges of antioxidant therapy for atrial fibrillation. |
| Q36936412 | Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias. |
| Q48194292 | Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits. |
| Q37248230 | Pleiotropic effects of statins in atrial fibrillation patients: the evidence |
| Q37244083 | Relationship between plasma level of vitamin D and post operative atrial fibrillation in patients undergoing CABG. |
| Q35688023 | Role of inflammation in atrial fibrillation pathophysiology and management. |
| Q45133063 | Serum γ-glutamyltransferase activity in patients with nonvalvular atrial fibrillation |
| Q88230582 | Sole and combined vitamin C supplementation can prevent postoperative atrial fibrillation after cardiac surgery: A systematic review and meta-analysis of randomized controlled trials |
| Q24603957 | Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism |
| Q34500520 | Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial) |
| Q33760881 | Statins Decrease Oxidative Stress and ICD Therapies. |
| Q36413428 | The clinical benefits of perioperative antioxidant vitamin therapy in patients undergoing cardiac surgery: a meta-analysis |
| Q37329977 | Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon |
| Q37546133 | Upstream therapy of atrial fibrillation |
| Q33851907 | Vitamin C Depletion and All-Cause Mortality in Renal Transplant Recipients |
| Q36265337 | Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis |
Search more.